Site Search
Search Results
ACS CAN Comments on DACA proposed rule
Access to care for those who are uninsured not only ensures that serious diseases like cancer can be detected and treated earlier but also often means better patient outcomes and less costs to the individual and the larger health care system. The Affordable Care Act (ACA) expanded health insurance coverage to millions of Americans. However, despite these coverage gains, thirteen years after the law was enacted approximately 31 million people in the United States remain uninsured with data showing that noncitizens are more likely to be uninsured. In 2021, 25% of lawfully present individuals and 46% of undocumented immigrants were uninsured, compared to only 8 percent of U.S. citizens. [1] Deferred Action ...
Survivor Views: Majority of Cancer Patients & Survivors Have or Expect to Have Medical Debt
Overview: The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views research panel. The panel is a group of cancer patients and survivors who respond to regular surveys and provide important insights to support ACS CAN’s advocacy work at all levels ...
Factors Influencing Cancer Disparities
The American Cancer Society Cancer Action Network (ACS CAN) believes everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of income, race, gender identity, sexual orientation, disability status, or where they live. From preventive screening and early detection, through ... with cancer. Clinical trials are also a key part of research and enable the development of better drugs and treatments for cancer. However, cost is often a barrier to enrollment because trial participants are frequently responsible for non-medical costs such as transportation and ...